# Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders

> **NCT05486806** · — · UNKNOWN · sponsor: **Brigham and Women's Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Neurodegenerative Diseases
- sca3
- MSA - Multiple System Atrophy
- Ataxia
- Synucleinopathies

## Interventions

- **DRUG:** 18F-PBR06
- **RADIATION:** 18F-PBR06

## Key facts

- **NCT ID:** NCT05486806
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2024-09-15
- **Final completion:** 2024-11-15
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05486806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05486806, "Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05486806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*